Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.

Autonomic dysfunction is common in hypertensives but may not cause diastolic dysfunction in resistant hypertension.

A woman with thymoma developed a rare chronic condition similar to graft versus host disease after surgery.

The document concludes that using gadolinium-based contrast agents during MRI can be linked to Nephrogenic Systemic Fibrosis in patients with severe kidney disease.

Women with androgenetic alopecia may have higher blood pressure levels.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

A very low-calorie ketogenic diet is effective for quick weight loss and improving health in obese patients, with careful management of side effects and maintenance.

The study found that diseases can be grouped by symptoms and that the accuracy of predicting disease-related genes varies with the data source.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Some birth control pills have a higher risk of blood clots than others.

SHBG may be a useful early indicator and treatment target for PCOS.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Obese people have more skin problems like stretch marks and infections, which get worse with higher obesity levels.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Fat cells are important for tissue repair and stem cell support in various body parts.